We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,407
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVGN icon
13951
CALL
Evogene
EVGN
$9.82M
$468 ﹤0.01%
80
-540
-87% -$4.73K
NCTY
13952
PUT
The9 Ltd
NCTY
$64.1M
$468 ﹤0.01%
70
-50
-42% -$428
ANY icon
13953
PUT
Sphere 3D
ANY
$18.4M
$466 ﹤0.01%
35
-1,608
-98% -$30.4K
MLSS icon
13954
PUT
Milestone Scientific
MLSS
$44.2M
$460 ﹤0.01%
+500
New +$527
ABTS icon
13955
PUT
Abits Group
ABTS
$4M
$455 ﹤0.01%
33
GTACW
13956
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
$451 ﹤0.01%
11,258
-72
-0.6% -$5
MSPRW
13957
DELISTED
MSP Recovery Inc Warrant
MSPRW
$449 ﹤0.01%
56,821
+16,336
+40% +$60
NMTC icon
13958
PUT
NeuroOne Medical Technologies
NMTC
$17M
$445 ﹤0.01%
+83
New +$556
ACAHW
13959
DELISTED
Atlantic Coastal Acquisition Corp. Warrant
ACAHW
$442 ﹤0.01%
15,787
+3,988
+34% +$111
AUUDW
13960
DELISTED
Auddia Inc Warrants
AUUDW
$441 ﹤0.01%
+11,015
New +$595
HPLTW
13961
DELISTED
Home Plate Acquisition Corporation Warrant
HPLTW
$439 ﹤0.01%
+14,035
New +$362
GRTX
13962
CALL
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$438 ﹤0.01%
2,500
-14,200
-85% -$17.6K
PUCKW
13963
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$435 ﹤0.01%
16,595
+1,728
+12% +$44
RAIN
13964
PUT
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$431 ﹤0.01%
500
-29,700
-98% -$32.5K
NGM
13965
CALL
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$428 ﹤0.01%
400
-2,000
-83% -$4.14K
EVGRW
13966
DELISTED
Evergreen Corporation Warrant
EVGRW
$417 ﹤0.01%
10,121
HYMCL
13967
DELISTED
Hycroft Mining Holding Corp Warrants
HYMCL
$416 ﹤0.01%
+13,859
New +$420
VIRX
13968
PUT
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$416 ﹤0.01%
400
-1,300
-76% -$1.76K
ITI
13969
PUT
DELISTED
Iteris, Inc.
ITI
$414 ﹤0.01%
100
-100
-50% -$426
TNONW icon
13970
Tenon Medical Inc Warrant
TNONW
$1.64K
$413 ﹤0.01%
+10,117
New +$743
XBIT icon
13971
CALL
XBiotech
XBIT
$71.6M
$412 ﹤0.01%
100
-1,800
-95% -$9.01K
AEG icon
13972
Aegon
AEG
$14B
$403 ﹤0.01%
84
-902,588
-100% -$4.65M
CLPS icon
13973
PUT
CLPS Inc
CLPS
$26.1M
$400 ﹤0.01%
400
-2,000
-83% -$2.1K
TTOO
13974
PUT
DELISTED
T2 Biosystems, Inc
TTOO
$398 ﹤0.01%
18
-156
-90% -$4.07K
OPAD.WS
13975
DELISTED
Offerpad Solutions Inc. Warrants, Every 15 warrants will be exercisable for one share of Class A Common Stock at an exercise price of $172.50 per share of Class A Common Stock
OPAD.WS
$398 ﹤0.01%
26,337
+14,297
+119% +$242

Similar funds

Citadel Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Citadel Advisors held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Citadel Advisors's Q3 2023 filing shows 1,407 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Citadel Advisors's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Citadel Advisors added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Citadel Advisors's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Citadel Advisors fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Citadel Advisors's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Citadel Advisors opened 1,407 new positions and closed 1,460 in Q3 2023.
  • Citadel Advisors's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.